{"altmetric_id":6410694,"counts":{"readers":{"mendeley":237,"citeulike":0,"connotea":1},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["fezziwig2008"],"posts_count":1}},"selected_quotes":["Mutant KRAS-predicts resistance to EGFR monoclonal Abs=major change in Rx of metas colon Ca $HALO HTI-1511 targeting"],"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fd1","authors":["Wendy De Roock","Veerle De Vriendt","Nicola Normanno","Fortunato Ciardiello","Sabine Tejpar"],"doi":"10.1016\/s1470-2045(10)70209-6","endpage":"603","first_seen_on":"2016-03-31T18:00:56+00:00","issns":["1470-2045","14702045"],"issue":"6","journal":"Lancet Oncology","last_mentioned_on":1459447237,"links":["http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1470204510702096"],"pdf_url":"http:\/\/www.thelancet.com\/article\/S1470204510702096\/pdf","pmid":"21163703","pubdate":"2010-12-15T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"594","subjects":["neoplasms"],"title":"KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer","type":"article","volume":"12","mendeley_url":"http:\/\/www.mendeley.com\/research\/kras-braf-pik3ca-pten-mutations-implications-targeted-therapies-metastatic-colorectal-cancer"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":7471181,"mean":6.4836306053357,"rank":5653940,"this_scored_higher_than_pct":13,"this_scored_higher_than":1000370,"rank_type":"exact","sample_size":7471181,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":272896,"mean":11.086611253412,"rank":191790,"this_scored_higher_than_pct":15,"this_scored_higher_than":42004,"rank_type":"exact","sample_size":272896,"percentile":15},"this_journal":{"total_number_of_other_articles":3314,"mean":16.765184424992,"rank":2750,"this_scored_higher_than_pct":4,"this_scored_higher_than":135,"rank_type":"exact","sample_size":3314,"percentile":4},"similar_age_this_journal_3m":{"total_number_of_other_articles":157,"mean":18.439512820513,"rank":131,"this_scored_higher_than_pct":3,"this_scored_higher_than":5,"rank_type":"exact","sample_size":157,"percentile":3}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":10,"Researcher":59,"Student  > Doctoral Student":17,"Student  > Ph. D. Student":56,"Student  > Postgraduate":13,"Other":27,"Student  > Master":29,"Student  > Bachelor":14,"Lecturer":2,"Professor":7},"by_discipline":{"Engineering":2,"Medicine and Dentistry":101,"Neuroscience":2,"Chemistry":4,"Social Sciences":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":96,"Biochemistry, Genetics and Molecular Biology":21,"Mathematics":1,"Unspecified":6,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"mendeley":{"CA":1,"EC":2,"NL":1,"US":2,"IE":1,"JP":1,"GB":3,"CL":1,"FR":1,"ES":2,"IN":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/fezziwig2008\/statuses\/715599694966206464","license":"gnip","citation_ids":[6410694],"posted_on":"2016-03-31T18:00:37+00:00","author":{"name":"fezziwig2008","image":"https:\/\/pbs.twimg.com\/profile_images\/556886909666873344\/X0bget2F_normal.png","description":"Occam's Razor-double edged sword- good data supports longs, decapitates shorts-Transients will be Blocked forever-on departure-tread lightly...tweets not advice","id_on_source":"fezziwig2008","tweeter_id":"376154503","geo":{"lt":null,"ln":null},"followers":1556},"tweet_id":"715599694966206464"}]}}